Novavax Inc. NVAX reported positive results from three vaccine trials on Tuesday, one targeting both COVID and flu, one for stand-alone flu and one a high-dose COVID vaccine. All three candidates produced robust immune response in Phase 2 trials and showed a reassuring preliminary safety profile, said Novavax. “The stand-alone influenza vaccine candidate achieved statistically significant hemagglutination inhibition (HAI) antibody responses 31 to 56% higher for all four strains compared to Fluad,” said the company. The highest-dose stand-alone COVID vaccine achieved statistically significant neutralization responses that…
You May Also Like
Clarence Thomas’ billionaire GOP megadonor pal Harlan Crow gave millions to dark money groups: CREW
Harlan Crow, the billionaire GOP megadonor under scrutiny for lavishing U.S. Supreme Court Justice Clarence…
- ReportWire
- June 16, 2023
Erdogan’s rival has gone through a political makeover ahead of the elections | CNN
Editor’s Note: A version of this story appears in CNN’s Meanwhile in…
- ReportWire
- May 12, 2023
Attack on Tunisian synagogue leaves four dead
A Tunisian naval guard attempted to attack a synagogue on Tuesday, fatally…
- ReportWire
- May 9, 2023
Uvalde school hires ex-trooper who responded to massacre
UVALDE, Texas — A former Texas state trooper who was part of…
- ReportWire
- October 6, 2022